Alternative Africa

Top Menu

  • Home
  • About Us
  • Privacy Policy
  • Terms of Use
  • Contact Us

Main Menu

  • Home
  • Arts & Culture
  • Business
  • Environment
  • Politics
  • Sports
  • Reports
    • Africa-Observers
      • Read Reports
      • Submit a story
  • MORE
    • Health
    • News Now
    • World
    • Technology
Sign in / Join

Login

Welcome! Login in to your account
Lost your password?

Lost Password

Back to login
  • Home
  • About Us
  • Privacy Policy
  • Terms of Use
  • Contact Us

logo

Alternative Africa

  • Home
  • Arts & Culture
  • Business
  • Environment
  • Politics
  • Sports
  • Reports
    • Africa-Observers
      • Read Reports
      • Submit a story
  • MORE
    • Health
    • News Now
    • World
    • Technology
  • Guinea president, Alpha Conde becomes first African leader to receive Covid-19 jab

  • Ghanaian Pastor murders daughter over witchcraft’ allegations, secretly buries her at cemetery

  • UK bans potentially deadly Chinese hand sanitiser containing toxic substance

  • Trump administration carries out 13th, final execution

  • Arsenal, Mesut Ozil ‘reach deal to terminate his £350k-a-week contract

HealthNews NowWorld
Home›Health›AstraZeneca begins covid vaccine trial to prevent infection in kids

AstraZeneca begins covid vaccine trial to prevent infection in kids

By alternativeafrica
November 21, 2020
224
0
Share:

London, Nov. 21, 2020 (AltAfrica)-AstraZeneca started late-stage trials on Saturday of an experimental long-acting monoclonal antibody combination drug it hopes could be used as a so-called prophylactic to prevent COVID-19 infection in at-risk people for up to 12 months.

AstraZeneca said its COVID-19 cocktail – which combines two monoclonal antibodies – has the potential both to treat and prevent disease progression in patients already infected with the SARS-CoV-2 virus, and to be given as a preventative medication prior to people such as healthcare workers being exposed to the virus. (Reuters Image)

The Phase III international clinical trial will recruit a total of 5 000 people across countries in Europe and the United States to assess the safety and effectiveness of the antibody cocktail, known as AZD7442.

READ ALSO: DONALD TRUMP JR. TESTS POSITIVE FOR COVID-19

The prophylactic treatment differs from a vaccine in that it introduces antibodies, rather than prompting the body’s immune system to make them. It may prove useful in people whose immune systems are weaker or compromised, and who don’t respond to vaccination. Separately, AstraZeneca is developing a COVID-19 vaccine in conjunction with researchers at Oxford University.

In Britain, where the trials of the monoclonal antibody combination kicked off on Saturday, 1 000 participants will be recruited at nine sites, researchers leading the UK arm said.

“What we are investigating in this study is whether we can provide protection by giving antibodies that have been shown to neutralise the virus, by injection into the muscle,” said said Andrew Ustianowski, a professor and chief investigator on the UK study.

“The hope is that this will then provide good protection for many months against infection.”

Monoclonal antibodies mimic natural antibodies that the body generates to fight off infection. They can be synthesised in the laboratory and are already used to treat some types of cancer.

AstraZeneca said its COVID-19 cocktail – which combines two monoclonal antibodies – has the potential both to treat and prevent disease progression in patients already infected with the SARS-CoV-2 virus, and to be given as a preventative medication prior to people such as healthcare workers being exposed to the virus.

“These have been engineered specifically to have what we call a long half-life, (so) we think they will confer protection for (at least) six, but more likely closer to 12 months,” Mene Pangalos, AstraZeneca’s executive vice president of bio pharmaceuticals R&D, told reporters at a briefing.

He said this made the cocktail, “in effect, almost like a passive vaccination.”

Alongside the 5 000-participant trial assessing the drug’s potential as a preventative, AstraZeneca also plans to evaluate AZD7442 as a post-exposure preventative and pre-emptive treatment in roughly 1 100 participants in trials in Europe and the United States.

The US government last month awarded $486 million to AstraZeneca to develop and secure supplies of up to 100,000 doses of the COVID-19 cocktail.

The UK government also has an in-principle agreement with AstraZeneca which it says secures access to a million doses of AZD7442 if it is successful in Phase III trials.

Under a plan to set up a global production network, Astra in October enlisted contract manufacturer Lonza to produce the drug in Portsmouth, New Hampshire, starting in the first half of 2021 

Reuters  |  @SABCNews

SHARE ON:
TagsAstraZenecaCovid-19 Vaccine Trials
Previous Article

Donald Trump Jr. tests positive for COVID-19

Next Article

Trump’s days are numbered as Republican state ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

alternativeafrica

Related articles More from author

  • AfricaHealthNews Now

    Covid-19 vaccine undergoes final test with 30 thousand volunteers

    July 28, 2020
    By alternativeafrica
  • HealthNews NowWorld

    American company, J&J to test COVID-19 vaccine in ages 12-18

    October 31, 2020
    By alternativeafrica
  • AfricaHealthNews Now

    South Africa enrols 500 health workers to test tuberculosis vaccine for coronavirus treatment

    May 5, 2020
    By alternativeafrica
  • HealthNews NowWorld

    Reduced Covid-19 outbreaks hampering vaccine trials-Scientists

    June 2, 2020
    By alternativeafrica
  • HealthNews NowWorld

    Pharma giant, AstraZeneca starts UK trial of drug that prevents, treats Covid-19

    August 26, 2020
    By alternativeafrica
  • AfricaNews Now

    Drogba, Eto’o reject ‘Covid-19 vaccine trials on Africans’

    April 4, 2020
    By alternativeafrica

Leave a reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You might be interested

  • News NowPolitics

    Gambian president swears in female vice Jallow-Tambajang

  • Anne's DiaryHealthNews Now

    How Your Height Impacts Your Health

  • AfricaBusinessNews Now

    Nigeria inaugurate 10,000 hectares oil-palm plantation to boost palm oil production

Timeline

  • January 17, 2021

    Guinea president, Alpha Conde becomes first African leader to receive Covid-19 jab

  • January 17, 2021

    Ghanaian Pastor murders daughter over witchcraft’ allegations, secretly buries her at cemetery

  • January 17, 2021

    UK bans potentially deadly Chinese hand sanitiser containing toxic substance

  • January 16, 2021

    Trump administration carries out 13th, final execution

  • January 16, 2021

    Arsenal, Mesut Ozil ‘reach deal to terminate his £350k-a-week contract

  • Popular

  • Comments

  • Lagos govt confirms first case of deadly coronavirus infection in Nigeria

    By alternativeafrica
    February 28, 2020
  • Keynote Address of President Nana Addo Dankwa Akufo-Addo at 2018 Oxford Africa Conference

    By PSJ Africa
    May 14, 2018
  • Morocco begins regional integration by connecting Casablanca Airport with High Speed Train

    By alternativeafrica
    January 4, 2020
  • Kenyan govt pressure Facebook for data on Kenyan users

    By alternativeafrica
    November 20, 2019
  • Nigeria: 32,000 capacity Lagos rice mill to start production in 2020

    By alternativeafrica
    December 23, 2019
  • The return of fortress conservation: why excluding people means biodiversity conservation will fail – Future agricultures
    on
    October 16, 2020

    Inside the training camp of Akashinga, Zimbabwe’s armed, all-women anti-poaching rangers

    […] In parallel to ...
  • The return of fortress conservation: why excluding people means biodiversity conservation will fail - The Zimbabwean
    on
    October 12, 2020

    Inside the training camp of Akashinga, Zimbabwe’s armed, all-women anti-poaching rangers

    […] In parallel to ...
  • Ethiopia joins Africa's Artificial Intelligence revolution | Alternative Africa
    on
    October 2, 2020

    Spending on Artificial Intelligence Systems in Africa, Middle East to top $374 million in 2020

    […] Many African countries ...
  • The 5 most popular Africans 2020
    on
    September 25, 2020

    Celebrating Congolese doctor Jean-Jacques Muyembe, the man behind breakthrough of Ebola cure

    […] Dr. Jean-Jacques Muyembe ...
  • Millitants in Central Mali Set Jail Ablaze in Attack Killing Two | taktik(z) GDI (Government Defense ...
    on
    August 11, 2020

    Fifteen gendarmes killed in another attack on Mali camp

    […] attack fol­lowed a January ...
AlternativeAfrica.com is an independent Pan African News Website dedicated primarily to influencing the negative narratives about Africa. We hope to do this by focusing and showcasing the many developmental strides sweeping across the continent.

Read more >>>

Contact Info

  • 22 Laburnum Court, Laburnum Road, Mitcham London, CR4 2NA, United Kingdom
  • +44(0)2036320939 | +44(0)7535019197 | +44(0)7305356327
  • info@alternativeafrica.com
  • Recent

  • Popular

  • Comments

  • Guinea president, Alpha Conde becomes first African leader to receive Covid-19 jab

    By alternativeafrica
    January 17, 2021
  • Ghanaian Pastor murders daughter over witchcraft’ allegations, secretly buries her at cemetery

    By alternativeafrica
    January 17, 2021
  • UK bans potentially deadly Chinese hand sanitiser containing toxic substance

    By alternativeafrica
    January 17, 2021
  • Trump administration carries out 13th, final execution

    By alternativeafrica
    January 16, 2021
  • Lagos govt confirms first case of deadly coronavirus infection in Nigeria

    By alternativeafrica
    February 28, 2020
  • Keynote Address of President Nana Addo Dankwa Akufo-Addo at 2018 Oxford Africa Conference

    By PSJ Africa
    May 14, 2018
  • Macron in Ivory Coast to launch anti-terrorism academy

    By alternativeafrica
    December 21, 2019
  • Kenyan govt pressure Facebook for data on Kenyan users

    By alternativeafrica
    November 20, 2019
  • The return of fortress conservation: why excluding people means biodiversity conservation will fail – Future agricultures
    on
    October 16, 2020

    Inside the training camp of Akashinga, Zimbabwe’s armed, all-women anti-poaching rangers

    […] In parallel to ...
  • The return of fortress conservation: why excluding people means biodiversity conservation will fail - The Zimbabwean
    on
    October 12, 2020

    Inside the training camp of Akashinga, Zimbabwe’s armed, all-women anti-poaching rangers

    […] In parallel to ...
  • Ethiopia joins Africa's Artificial Intelligence revolution | Alternative Africa
    on
    October 2, 2020

    Spending on Artificial Intelligence Systems in Africa, Middle East to top $374 million in 2020

    […] Many African countries ...
  • The 5 most popular Africans 2020
    on
    September 25, 2020

    Celebrating Congolese doctor Jean-Jacques Muyembe, the man behind breakthrough of Ebola cure

    […] Dr. Jean-Jacques Muyembe ...

Photostream

    Follow us

    • Home
    • About Us
    • Privacy Policy
    • Terms of Use
    • Contact Us
    © Copyright Alternative Africa 2019. All rights reserved.